Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Revolax Fine with Lidocaine vs Restylane Refyne for Nasolabial Fold Correction
TCTR20241215015Phase 3Active, not recruiting
- Sponsor
- ACROSS Group
- Start
- Apr 2025
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in None (2 arms), sponsored by ACROSS Group. Started Apr 2025; status: active, not recruiting.
Beyond the preview
Go deeper on TCTR20241215015.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20241215015.